Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1990 1
1991 1
1993 1
1999 1
2002 1
2003 3
2004 2
2005 3
2006 3
2007 3
2008 6
2009 4
2010 5
2011 5
2012 5
2013 6
2014 4
2015 8
2016 7
2017 7
2018 10
2019 7
2020 8
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

97 results
Results by year
Filters applied: . Clear all
Page 1
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
Kumar SK, Callander NS, Adekola K, Anderson L, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Kang Y, Hultcrantz M, Larson S, Liedtke M, Martin T, Omel J, Shain K, Sborov D, Stockerl-Goldstein K, Weber D, Keller J, Kumar R. Kumar SK, et al. Among authors: huff ca. J Natl Compr Canc Netw. 2020 Dec 2;18(12):1685-1717. doi: 10.6004/jnccn.2020.0057. J Natl Compr Canc Netw. 2020. PMID: 33285522
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.
Kumar SK, Callander NS, Hillengass J, Liedtke M, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Cornell RF, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Holmberg L, Htut M, Huff CA, Kang Y, Landgren O, Malek E, Martin T, Omel J, Raje N, Sborov D, Singhal S, Stockerl-Goldstein K, Tan C, Weber D, Johnson-Chilla A, Keller J, Kumar R. Kumar SK, et al. Among authors: huff ca. J Natl Compr Canc Netw. 2019 Oct 1;17(10):1154-1165. doi: 10.6004/jnccn.2019.0049. J Natl Compr Canc Netw. 2019. PMID: 31590151
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
Chari A, Vogl DT, Gavriatopoulou M, Nooka AK, Yee AJ, Huff CA, Moreau P, Dingli D, Cole C, Lonial S, Dimopoulos M, Stewart AK, Richter J, Vij R, Tuchman S, Raab MS, Weisel KC, Delforge M, Cornell RF, Kaminetzky D, Hoffman JE, Costa LJ, Parker TL, Levy M, Schreder M, Meuleman N, Frenzel L, Mohty M, Choquet S, Schiller G, Comenzo RL, Engelhardt M, Illmer T, Vlummens P, Doyen C, Facon T, Karlin L, Perrot A, Podar K, Kauffman MG, Shacham S, Li L, Tang S, Picklesimer C, Saint-Martin JR, Crochiere M, Chang H, Parekh S, Landesman Y, Shah J, Richardson PG, Jagannath S. Chari A, et al. Among authors: huff ca. N Engl J Med. 2019 Aug 22;381(8):727-738. doi: 10.1056/NEJMoa1903455. N Engl J Med. 2019. PMID: 31433920 Clinical Trial.
A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma.
O'Donnell EK, Laubach JP, Yee AJ, Chen T, Huff CA, Basile FG, Wade PM, Paba-Prada CE, Ghobrial IM, Schlossman RL, Burke JN, Harrington CC, Lively KJ, Lyons HF, Munshi NC, Anderson KC, Trippa L, Richardson PG, Raje NS. O'Donnell EK, et al. Among authors: huff ca. Br J Haematol. 2018 Jul;182(2):222-230. doi: 10.1111/bjh.15261. Epub 2018 May 8. Br J Haematol. 2018. PMID: 29740809 Free PMC article. Clinical Trial.
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.
Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF, Huff CA, Matsui W, Bolaños-Meade J, Borrello I, Powell JD, Harrington E, Warnock S, Flowers M, Brodsky RA, Sandmaier BM, Storb RF, Jones RJ, Fuchs EJ. Luznik L, et al. Among authors: huff ca. Biol Blood Marrow Transplant. 2008 Jun;14(6):641-50. doi: 10.1016/j.bbmt.2008.03.005. Biol Blood Marrow Transplant. 2008. PMID: 18489989 Free PMC article. Clinical Trial.
Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation.
Imus PH, Blackford AL, Bettinotti M, Luznik L, Fuchs EJ, Huff CA, Gladstone DE, Ambinder RF, Borrello IM, Fuchs RJ, Swinnen LJ, Wagner-Johnston N, Gocke CB, Ali SA, Bolaños-Meade FJ, Jones RJ, Dezern AE. Imus PH, et al. Among authors: huff ca. Biol Blood Marrow Transplant. 2019 Dec;25(12):2431-2437. doi: 10.1016/j.bbmt.2019.07.027. Epub 2019 Aug 5. Biol Blood Marrow Transplant. 2019. PMID: 31394272 Free PMC article.
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide.
DeZern AE, Zahurak ML, Symons HJ, Cooke KR, Rosner GL, Gladstone DE, Huff CA, Swinnen LJ, Imus P, Borrello I, Wagner-Johnston N, Ambinder RF, Luznik L, Bolaños-Meade J, Fuchs EJ, Jones RJ, Brodsky RA. DeZern AE, et al. Among authors: huff ca. Blood Adv. 2020 Apr 28;4(8):1770-1779. doi: 10.1182/bloodadvances.2020001729. Blood Adv. 2020. PMID: 32343796 Free PMC article.
Multiple Myeloma: Current Advances and Future Directions.
Martin T, Huff CA. Martin T, et al. Among authors: huff ca. Clin Lymphoma Myeloma Leuk. 2019 May;19(5):255-263. doi: 10.1016/j.clml.2019.03.025. Epub 2019 Apr 1. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31130488 Review.
Multiple myeloma.
Anderson KC, Alsina M, Bensinger W, Biermann JS, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Faber EA Jr, Gasparetto C, Huff CA, Kassim A, Medeiros BC, Meredith R, Raje N, Schriber J, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Tricot G, Weber DM, Yahalom J, Yunus F; National Comprehensive Cancer Network. Anderson KC, et al. Among authors: huff ca. J Natl Compr Canc Netw. 2011 Oct;9(10):1146-83. doi: 10.6004/jnccn.2011.0095. J Natl Compr Canc Netw. 2011. PMID: 21975914 No abstract available.
Multiple myeloma cancer stem cells.
Huff CA, Matsui W. Huff CA, et al. J Clin Oncol. 2008 Jun 10;26(17):2895-900. doi: 10.1200/JCO.2007.15.8428. J Clin Oncol. 2008. PMID: 18539970 Free PMC article. Review.
97 results